Overview
Cervical Cancer screening is the systematic testing of asymptomatic women to detect precancerous changes and early cancer of the cervix, enabling treatment before invasive disease develops. Because most Cervical Cancer is caused by persistent infection with high-risk human papillomavirus, screening targets the long, detectable precancerous phase that precedes malignancy. The principal methods are cervical cytology, the Papanicolaou test, which examines exfoliated cervical cells for abnormalities; high-risk HPV testing, which detects the viral types that drive carcinogenesis; and visual inspection approaches used in lower-resource settings, with biomarkers and immunohistochemical markers increasingly used to refine risk. Abnormal results are followed by colposcopy, biopsy, and treatment of high-grade lesions, making screening one of the most effective forms of cancer prevention. Uptake is shaped by awareness, access, cultural and structural factors, and the strength of health systems, and equity in coverage is a persistent concern. The articles collected here address the uptake of Cervical Cancer screening across diverse populations, including referral-hospital and university-staff cohorts and refugee women, awareness among women of childbearing age, abnormal Pap smears, the role of human papillomavirus in carcinogenesis, and immunohistochemical evaluation of cervical lesions. Recurring themes include screening uptake and its determinants, HPV-driven carcinogenesis, cytological and molecular detection, and prevention of Cervical Cancer. The topic sits within gynaecological oncology, women's health, and public health.
Research published in this journal
9 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Uptake of Cervical Cancer Screening Among Female Staff at the University College Hospital, Ibadan
Awareness of Cervical Cancer Screening test Among Women of Child Bearing age in the Rural Area of Awo-Omamma, Imo State, Nigeria.
The Prevalence of Abnormal Cervical Pap Smears in Women with Morbid Obesity in Dubai, United Arab Emirates
Review: The Role of Human Papillomavirus in Virus-Induced Carcinogenesis
P16/INK4a and KI-67 Evaluation of Intraepithelial and Benign Cervical Lesions at the University College Hospital, Ibadan - A Retrospective Immunohistochemically Study
Cervical Cancer with The Active And Stable PI3K/MTOR/AKT Pathway In Azerbaijan Patients
Gene-Eden-VIR: A Potential Natural Treatment for Cervical Cancer
How this research is being cited
The 9 articles above have been cited 6 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Ibnosina Journal of Medicine and Biomedical Sciences
-
2023 · Ibnosina Journal of Medicine and Biomedical Sciences
-
2021 · Journal of the Scientific Society
-
2020 · International Journal of Human and Health Sciences (IJHHS)
-
Siti Mariam Ja’afar et al. · 2020 ·
-
2017 · Journal of Cancer Genetics and Biomarkers
A sample of recent works citing this journal's research on Cervical Cancer Screening, linking to each citing work.